Stable Differences in Intrinsic Mitochondrial Membrane Potential of Tumor Cell Subpopulations Reflect Phenotypic Heterogeneity
暂无分享,去创建一个
[1] Paolo Vineis,et al. Cell selection as driving force in lung and colon carcinogenesis. , 2010, Cancer research.
[2] King-Jen Chang,et al. Effects of Monascus-Fermented Rice Extract on Malignant Cell—Associated Neovascularization and Intravasation Determined Using the Chicken Embryo Chorioallantoic Membrane Model , 2010, Integrative cancer therapies.
[3] Lani F. Wu,et al. Cellular Heterogeneity: Do Differences Make a Difference? , 2010, Cell.
[4] D. Dressman,et al. Heteroplasmic mitochondrial DNA mutations in normal and tumor cells , 2010, Nature.
[5] D. Turnbull,et al. Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations , 2010, Brain : a journal of neurology.
[6] Keshav K. Singh,et al. mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice , 2009, Journal of Human Genetics.
[7] Keshav K. Singh,et al. Cancer cell mitochondria confer apoptosis resistance and promote metastasis , 2009, Cancer biology & therapy.
[8] Xinmin Cao,et al. GRIM-19 is essential for maintenance of mitochondrial membrane potential. , 2008, Molecular biology of the cell.
[9] I. Hassinen,et al. Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates , 2007, Journal of Biological Chemistry.
[10] C. Chi,et al. Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion. , 2007, Mitochondrion.
[11] Josephine C. Adams,et al. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas , 2006, BMC Cancer.
[12] J. P. McCoy,et al. The Mammalian Target of Rapamycin (mTOR) Pathway Regulates Mitochondrial Oxygen Consumption and Oxidative Capacity* , 2006, Journal of Biological Chemistry.
[13] E. Gottlieb,et al. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.
[14] J. Smeitink,et al. Mitochondrial complex I: Structure, function and pathology , 2006, Journal of Inherited Metabolic Disease.
[15] D. Fishman,et al. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation. , 2006, Cancer letters.
[16] L. Augenlicht,et al. Growth properties of colonic tumor cells are a function of the intrinsic mitochondrial membrane potential. , 2006, Cancer research.
[17] L. Augenlicht,et al. The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression. , 2005, Cancer research.
[18] J R Griffiths,et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.
[19] P. Beaune,et al. Clinical value of mitochondrial mutations in colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] L. Ellis,et al. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] S. Nanko,et al. Mitochondrial DNA 3644T-->C mutation associated with bipolar disorder. , 2004, Genomics.
[22] Napoleone Ferrara,et al. Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.
[23] M. Schlame,et al. Remodeling of Cardiolipin by Phospholipid Transacylation* , 2003, Journal of Biological Chemistry.
[24] S. Dimauro,et al. Phospholipid abnormalities in children with Barth syndrome. , 2003, Journal of the American College of Cardiology.
[25] N. Koshikawa,et al. Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model , 2003, Oncogene.
[26] Ronald J A Wanders,et al. Only One Splice Variant of the Human TAZ Gene Encodes a Functional Protein with a Role in Cardiolipin Metabolism* , 2003, Journal of Biological Chemistry.
[27] Andrew J. Wilson,et al. The intrinsic mitochondrial membrane potential (Deltapsim) is associated with steady-state mitochondrial activity and the extent to which colonic epithelial cells undergo butyrate-mediated growth arrest and apoptosis. , 2003, Cancer research.
[28] R. Carroll,et al. Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. , 2002, Carcinogenesis.
[29] D. Sabatini,et al. mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.
[30] Luca Scorrano,et al. A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. , 2002, Cancer cell.
[31] J. Mariadason,et al. Dissociation of staurosporine-induced apoptosis from G2-M arrest in SW620 human colonic carcinoma cells: initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential (deltapsim). , 2000, Cancer research.
[32] J. Mariadason,et al. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. , 2000, Cancer research.
[33] M. L. Greenberg,et al. Absence of Cardiolipin in the crd1 Null Mutant Results in Decreased Mitochondrial Membrane Potential and Reduced Mitochondrial Function* , 2000, The Journal of Biological Chemistry.
[34] N. Uesugi,et al. Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. , 2000, Gastroenterology.
[35] R. Kucherlapati,et al. Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa. , 1999, Cancer research.
[36] J. Mariadason,et al. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[37] P. Vreken,et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060) , 1999, Journal of Inherited Metabolic Disease.
[38] L. Augenlicht,et al. Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity. , 1999, Cancer research.
[39] Bert Vogelstein,et al. Somatic mutations of the mitochondrial genome in human colorectal tumours , 1998, Nature Genetics.
[40] T. Sugai,et al. Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: Evidence for mismatch repair systems in mitochondrial genome , 1998, Oncogene.
[41] L. Augenlicht,et al. Mitochondrial Membrane Potential (ΔΨmt) in the Coordination of p53-independent Proliferation and Apoptosis Pathways in Human Colonic Carcinoma Cells , 1998 .
[42] Y. Oshika,et al. © 1998 Cancer Research Campaign , 2022 .
[43] G. Mazzacca,et al. Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. , 1996, Gastroenterology.
[44] M. Mandal,et al. Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[45] K. Mimori,et al. Overexpression of matrix metalloproteinase‐7 mRNA in human colon carcinomas , 1995, Cancer.
[46] Jack P. Witty,et al. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. , 1994, Cancer research.
[47] L. Augenlicht,et al. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. , 1994, Cancer research.
[48] J. Lupton,et al. Butyrate as a differentiating agent: pharmacokinetics, analogues and current status. , 1994, Cancer letters.
[49] P. Gibson,et al. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. , 1993, Gut.
[50] L. Augenlicht,et al. Effects of fatty acids on expression of genes encoding subunits of cytochrome c oxidase and cytochrome c oxidase activity in HT29 human colonic adenocarcinoma cells. , 1991, The Journal of biological chemistry.
[51] G. Ronco,et al. New stable butyrate derivatives alter proliferation and differentiation in human mammary cells , 1991, International journal of cancer.
[52] T. Smith,et al. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. , 1991, Biochemistry.
[53] J. Modica-Napolitano,et al. Aberrant mitochondria in two human colon carcinoma cell lines. , 1989, Cancer research.
[54] W. Roediger. Bacterial short‐chain fatty acids and mucosal diseases of the colon , 1988, The British journal of surgery.
[55] G. Macfarlane,et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.
[56] E. Kurschel,et al. Clinical pharmacology of sodium butyrate in patients with acute leukemia. , 1987, European journal of cancer & clinical oncology.
[57] T. Lampidis,et al. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. , 1985, The Journal of biological chemistry.
[58] G. Azzone,et al. 'Cross-talk' between redox- and ATP-driven H+ pumps. , 1984, Biochemical Society transactions.
[59] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[60] J. Cummings. FERMENTATION IN THE HUMAN LARGE INTESTINE: EVIDENCE AND IMPLICATIONS FOR HEALTH , 1983, The Lancet.
[61] I. Summerhayes,et al. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[62] W. Roediger. Utilization of nutrients by isolated epithelial cells of the rat colon. , 1982, Gastroenterology.
[63] A. Leibovitz,et al. Classification of human colorectal adenocarcinoma cell lines. , 1976, Cancer research.
[64] A. Long,et al. A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.
[65] P. Goldman. The carbon-fluorine bond in compounds of biological interest. , 1969, Science.
[66] P. Ms,et al. THE SPECIALTY OF MEDICAL ADMINISTRATION. , 1965 .
[67] W. E. W. ROEDlGER. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man , 2006 .
[68] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[69] T. Ishikawa,et al. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin , 2004, Clinical & Experimental Metastasis.
[70] Josephine C. Adams,et al. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. , 2003, The American journal of pathology.
[71] G.,et al. Effects of Fatty Acids on Expression of Genes Encoding Subunits of Cytochrome c Oxidase and Cytochrome c Oxidase Activity in HT 29 Human Colonic Adenocarcinoma Cells * , 2001 .
[72] Wim H. M. Saris,et al. Proceedings of the American Association for Cancer Research. , 2001 .
[73] F. González,et al. Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. , 1998, JPEN. Journal of parenteral and enteral nutrition.
[74] H. Schulz. Oxidation of fatty acids , 1996 .
[75] G. Singh,et al. Energetic characteristics of cisplatin resistant ovarian carcinoma cells. , 1996, Anticancer research.
[76] L. B. Chen,et al. Mitochondrial membrane potential in living cells. , 1988, Annual review of cell biology.
[77] J. Wong,et al. Recent Advances in the Study of Mitochondria in Living Cells , 1988 .
[78] A. Ravid,et al. Effect of polar organic compounds on leukemic cells: Butyrate‐induced partial remission of acute myelogenous leukemia in a child , 1983, Cancer.
[79] K. Sepkowitz,et al. A study of some mitochondrial and peroxisomal enzymes in human colonic adenocarcinoma. , 1981, Laboratory investigation; a journal of technical methods and pathology.